Search results
The rise and fall of Elizabeth Holmes, the former Theranos CEO
INSIDER via Yahoo News· 7 hours agoShe asked anyone who visited the company’s headquarters to sign non-disclosure agreements before...
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a...
WPRI Providence· 2 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the first patient had been dosed in the Phase ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoPharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 PR Newswire DAEJEON, South Korea, May ...
5 Small Drug Stocks to Buy From a Recovering Industry
Zacks via Yahoo Finance· 1 day agoInnovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX,...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 3 days agoThe subcutaneous formulation of Opdivo is co-formulated with Halozyme’s proprietary recombinant...
Harrow (NASDAQ:HROW) Price Target Raised to $26.00
ETF DAILY NEWS· 7 days agoHarrow (NASDAQ:HROW – Free Report) had its price target lifted by Craig Hallum from $24.00 to $26.00 in a research report sent to investors on Wednesday, Benzinga reports. Craig Hallum currently ...
Closed Loop Medicine Appoints Paul Johnson as Non-Executive Director
Benzinga· 4 days agoClosed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today ...
Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive...
Digital Journal· 5 days agoAbout PredictrPK PredictrPK are precision-guided dosing...PredictrPK combines serology markers, patient- and disease-specific variables, current dosing, and proprietary machine-learning ...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
Digital Journal· 3 days agoOver...weeks, Rakovina Therapeutics aims to screen over five billion potential drug candidates using this platform. The most promising lead candidates will be further validated ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoEngitix Ltd (‘Engitix’), a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary human ...